T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Zoom
ZM
|
+$2.88B |
| 2 |
Eli Lilly
LLY
|
+$2.63B |
| 3 |
AstraZeneca
AZN
|
+$1.96B |
| 4 |
Fortinet
FTNT
|
+$1.66B |
| 5 |
Coupang
CPNG
|
+$1.63B |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
+$2.58B |
| 2 |
Morgan Stanley
MS
|
+$2.29B |
| 3 |
Airbnb
ABNB
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.8B |
| 5 |
Qualcomm
QCOM
|
+$1.79B |
Sector Composition
| 1 | Technology | 23.37% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Provident Bancorp
PVBC
$226M
| $24.2M | ﹤0.01% |
1,681,191
-4,296
| -0.3% | -$61.9K |
|
1227
Stoke Therapeutics
STOK
$1.29B
| $24.2M | ﹤0.01% |
623,192
-126,434
| -17% | -$4.91M |
|
|
SWTX
1228
DELISTED
SpringWorks Therapeutics
SWTX
| $24.1M | ﹤0.01% |
327,679
+1,499
| +0.5% | +$110K |
|
1229
John B. Sanfilippo & Son
JBSS
$737M
| $24M | ﹤0.01% |
265,340
-22,943
| -8% | -$2.07M |
|
1230
Wabtec
WAB
$32.3B
| $23.9M | ﹤0.01% |
302,534
-899,025
| -75% | -$71.2M |
|
1231
American Airlines Group
AAL
$8.54B
| $23.9M | ﹤0.01% |
999,029
+652
| +0.1% | +$15.6K |
|
1232
Protagonist Therapeutics
PTGX
$3.66B
| $23.7M | ﹤0.01% |
913,590
+68,195
| +8% | +$1.77M |
|
|
ABCM
1233
DELISTED
Abcam plc American Depositary Shares
ABCM
| $23.6M | ﹤0.01% |
1,227,632
+27,022
| +2% | +$519K |
|
1234
Eastman Chemical
EMN
$7.71B
| $23.6M | ﹤0.01% |
214,170
-18,150
| -8% | -$2M |
|
1235
FMC
FMC
$4.79B
| $23.5M | ﹤0.01% |
212,611
-13,999
| -6% | -$1.55M |
|
1236
STRATTEC Security
STRT
$283M
| $23.5M | ﹤0.01% |
500,632
-1,617
| -0.3% | -$75.8K |
|
|
MORF
1237
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $23.4M | ﹤0.01% |
+370,507
| New | +$23.4M |
|
1238
Service Corp International
SCI
$11.2B
| $23.3M | ﹤0.01% |
456,077
-480,728
| -51% | -$24.5M |
|
1239
Solid Biosciences
SLDB
$420M
| $23.3M | ﹤0.01% |
+280,600
| New | +$23.3M |
|
1240
Columbia Financial
CLBK
$1.6B
| $23.1M | ﹤0.01% |
1,320,765
-95,629
| -7% | -$1.67M |
|
1241
Pultegroup
PHM
$27B
| $23M | ﹤0.01% |
437,752
-34,666
| -7% | -$1.82M |
|
1242
Boston Properties
BXP
$12.2B
| $22.8M | ﹤0.01% |
225,496
-16,648
| -7% | -$1.69M |
|
1243
Diageo
DEO
$56.5B
| $22.7M | ﹤0.01% |
138,492
+2,352
| +2% | +$386K |
|
1244
J.M. Smucker
SJM
$11.5B
| $22.7M | ﹤0.01% |
179,592
-20,897
| -10% | -$2.64M |
|
1245
Murphy USA
MUSA
$7.53B
| $22.6M | ﹤0.01% |
156,671
-131,418
| -46% | -$19M |
|
1246
908 Devices
MASS
$202M
| $22.6M | ﹤0.01% |
465,287
-107,713
| -19% | -$5.22M |
|
1247
Whirlpool
WHR
$5.15B
| $22.4M | ﹤0.01% |
101,742
-6,172
| -6% | -$1.36M |
|
|
CCXI
1248
DELISTED
ChemoCentryx, Inc.
CCXI
| $22.4M | ﹤0.01% |
436,276
+33,148
| +8% | +$1.7M |
|
1249
Saic
SAIC
$4.9B
| $22.3M | ﹤0.01% |
266,310
-213,592
| -45% | -$17.9M |
|
1250
Williams-Sonoma
WSM
$24B
| $22.1M | ﹤0.01% |
246,420
-8,108
| -3% | -$726K |
|